The Lancet Oncology in conversation with

Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

September 29, 2020 The Lancet
The Lancet Oncology in conversation with
Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer
Show Notes

Paul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv